Mirador Capital Partners LP Abb Vie Inc. Transaction History
Mirador Capital Partners LP
- $536 Million
- Q1 2025
A detailed history of Mirador Capital Partners LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 54,724 shares of ABBV stock, worth $10.2 Million. This represents 2.14% of its overall portfolio holdings.
Number of Shares
54,724
Previous 52,190
4.86%
Holding current value
$10.2 Million
Previous $9.27 Million
23.63%
% of portfolio
2.14%
Previous 1.75%
Shares
32 transactions
Others Institutions Holding ABBV
# of Institutions
4,270Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.5 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.2 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.69 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $330B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...